Remedy Entertainment Plc | Company Announcement 1:15 pm (EEST) 13 April 2022
Resolutions by Remedy Entertainment Plc’s Annual General Meeting and Board of Directors
Annual General Meeting
Remedy Entertainment Plc’s Annual General Meeting was held in Espoo on 13 April 2022. The meeting approved the financial statements and discharged the members of the Board of Directors and the CEO from liability for the financial period 1 January–31 December 2021.
Dividend
The Annual General Meeting decided on a dividend of EUR 0.17 per share, i.e. EUR 2,261,459.00 in the aggregate, to be paid from the financial period that ended on 31 December 2021. The record date for the dividend payment is 19 April 2022 and the payment date is 26 April 2022.
Board of Directors
The Annual General Meeting confirmed that the number of Board members is six. Markus Mäki, Christian Fredrikson, Jussi Laakkonen and Henri Österlund will continue as members of the Board of Directors. Kaisa Salakka and Sonja Ängeslevä were elected as new Board members. Unlike the other Board members, the term of office of Sonja Ängeslevä commences on 2 May 2022.
The Annual General Meeting confirmed that the remuneration payable to the Chairman of the Board of Directors is EUR 4,500 per month and each Board member EUR 3,000 per month.
Auditor
The Annual General Meeting re-elected KPMG Oy Ab as the auditor of the company with APA Petri Sammalisto acting as the auditor with the principal responsibility. The auditor’s fee is paid according to reasonable invoice presented to the company.
Authorization for the directed repurchase of own shares
The Annual General Meeting authorized the Board of Directors to resolve on the directed repurchase of a maximum of 500,000 of the company’s own shares in one or more instalments by using company’s unrestricted equity. The authorization is valid until the closing of the next Annual General Meeting, however, no longer than 13 October 2023 and it replaces the previous authorizations to repurchase the Company’s own shares.
Authorization to decide on share issues or issuance of option rights or other special rights
The Annual General Meeting authorized the Board of Directors to resolve on the issuance of shares for a fee or without a fee or issuances of option rights or special rights so that the number of shares to be issued can be at maximum 1,300,000. The issued shares can be new or treasury shares held by the company. Shares can be issued also in deviation from the shareholders’ pre-emptive rights. The authorization is valid for five years from the date of the Annual General Meeting and it replaces the previous authorizations for share issues or stock options.
Organizing meeting of the Board of Directors
At its organizing meeting held after the Annual General Meeting the Board elected Markus Mäki to continue as the Chairman of the Board of Directors.
In Espoo, 13 April 2022
Remedy Entertainment Plc
The Board of Directors
More information
Tero Virtala, CEO
Phone: +358 9 435 5040
Email: tero.virtala@remedygames.com
Veli-Pekka Puolakanaho, Corporate Development Director
Phone: +358 50 430 0936
Email: veli-pekka.puolakanaho@remedygames.com
Aktia Alexander Corporate Finance Oy, Certified Adviser
Phone: +358 50 520 4098
About Remedy
Remedy Entertainment Plc is a globally successful video game company known for story-driven and visually stunning console and PC games such as Control, Alan Wake and Max Payne. Remedy also develops its own Northlight game engine and game development tools. Founded in 1995 and based in Finland, the company employs over 320 game industry professionals from 32 different countries. Remedy is listed on the Nasdaq First North Growth Market Finland marketplace. www.remedygames.com
Distribution
Nasdaq Helsinki Ltd
Key media
www.remedygames.com